Literature DB >> 28291069

TWO CASES OF ACUTE RETINAL NECROSIS DUE TO VARICELLA ZOSTER DESPITE PRIOR SHINGLES VACCINATION.

Eric J Weinlander1, Angeline L Wang, Pimkwan Jaru-Ampornpan, Michael M Altaweel, T Michael Nork.   

Abstract

PURPOSE: To review two cases of acute retinal necrosis in adults due to varicella zoster virus despite prior shingles vaccination.
METHODS: Retrospective chart review. PATIENTS: A 62-year-old man and a 64-year-old man with unilateral acute retinal necrosis who had shingles vaccinations 16 and 7 months before their ocular symptoms.
RESULTS: Polymerase chain reaction confirmation of varicella zoster virus in the anterior chambers of both patients. Both patients had good responses to oral antiviral therapy and topical and/or oral steroids. DISCUSSION: These two cases demonstrate that singles vaccination is not an absolute protection against varicella zoster virus-related acute retinal necrosis. However, such vaccination may reduce the severity of the acute retinal necrosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 28291069      PMCID: PMC5597443          DOI: 10.1097/ICB.0000000000000567

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  10 in total

1.  Acute retinal necrosis after herpes zoster vaccination.

Authors:  Leon D Charkoudian; Gregg M Kaiser; Robert L Steinmetz; Sunil K Srivastava
Journal:  Arch Ophthalmol       Date:  2011-11

2.  Retinal necrosis following varicella-zoster vaccination.

Authors:  John A Gonzales; Ashleigh L Levison; Jay M Stewart; Nisha R Acharya; Todd P Margolis
Journal:  Arch Ophthalmol       Date:  2012-10

3.  Bilateral acute retinal necrosis.

Authors:  N J Young; A C Bird
Journal:  Br J Ophthalmol       Date:  1978-09       Impact factor: 4.638

Review 4.  Emerging concepts in the management of acute retinal necrosis.

Authors:  Robert William Wong; J Michael Jumper; H Richard McDonald; Robert N Johnson; Arthur Fu; Brandon J Lujan; Emmett T Cunningham
Journal:  Br J Ophthalmol       Date:  2012-12-12       Impact factor: 4.638

5.  Acute retinal necrosis features, management, and outcomes.

Authors:  Chun H Lau; Tom Missotten; Joel Salzmann; Susan L Lightman
Journal:  Ophthalmology       Date:  2006-12-20       Impact factor: 12.079

6.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

7.  Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host.

Authors:  Y Guex-Crosier; C Rochat; C P Herbort
Journal:  Ocul Immunol Inflamm       Date:  1997-12       Impact factor: 3.070

Review 8.  The safety profile of varicella vaccine: a 10-year review.

Authors:  Susan A Galea; Ann Sweet; Paul Beninger; Sharon P Steinberg; Philip S Larussa; Anne A Gershon; Robert G Sharrar
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

9.  Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

Authors:  Thomas W Harper; Darlene Miller; Joyce C Schiffman; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

10.  Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK.

Authors:  M N Muthiah; M Michaelides; C S Child; S M Mitchell
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.